Published on
November 25, 2025
- 16:00 GMT
First Patients Enrolled in Groundbreaking Brain Cancer Study at Nationally Recognized Academic Medical Center
Exvade Bioscience today announced it has enrolled its first patients in a Phase 1 Trial at the Preston Robert Tisch Brain Tumor Center at Duke University. REDMOND, WA, UNITED STATES, November 25, 2025 /EINPresswire.com/ -- Exvade Bioscience, a …
Distribution channels:
Business & Economy, Companies
...
